Innerzyme

Pain & Inflammation Blend

D
N+ Score66
Herbal & BotanicalServing: 4 Tablet(s)Type: Other Combinations

Innerzyme Pain & Inflammation Blend is an herbal and botanical combination supplement with 8 ingredients. This product includes a blend of enzymes such as Pancreatin 4X (750mg), Papain (6,000,000 USP), Bromelain (720 GDU), Trypsin (9,000 USP), and Chymotrypsin (250 USP), alongside Rutin (400mg), White Willow Bark Extract (100mg), and Turmeric (100mg). However, none of the ingredients are listed at clinically studied doses based on current research. It has an N+ Score of 66, earning a D grade, which places it in the average quality tier. This blend may appeal to individuals interested in enzyme and botanical support for general wellness, but specific efficacy is not supported by clinical dosing.

About This Product

Pain & Inflammation Blend by Innerzyme is a herbal & botanical supplement containing 8 active ingredients. It has earned an N+ Score of 66/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (8 ingredients)

IngredientAmountDose Adequacy
Bromelain720.000 GDUN/A
Papain6000000.000 USPN/A
Rutin400.000 mgN/A
Trypsin9000.000 USPN/A
Chymotrypsin250.000 USPN/A
Turmeric100.000 mgN/A
White Willow bark extract100.000 mgN/A
Pancreatin 4x750.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.